(Q38109282)

English

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.

scientific article published on 22 May 2013

Statements

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit